"Vi vandrer med freidig mot". Om skolevandring - fra skoleleders og lærers perspektiv

Autor: Aas, Ellen

Publikováno v: Aas, Ellen. "Vi vandrer med freidig mot". Om skolevandring - fra skoleleders og lærers perspektiv. Master thesis, University of Oslo, 2015

Externí odkaz: http://hdl.handle.net/10852/48968
https://www.duo.uio.no/bitstream/handle/10852/48968/1/Endelig-ByomNilssen-og-Aas.pdf

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Improved cholesterol phenotype analysis by a model relating lipoprotein life cycle processes to particle size[S]

Autor: Daniël B. van Schalkwijk, Albert A. de Graaf, Ben van Ommen, Kees van Bochove, Patrick C.N. Rensen, Louis M. Havekes, Niek C.A. van de Pas, Huub C.J. Hoefsloot, Jan van der Greef, Andreas P. Freidig

Publikováno v: Journal of Lipid Research, Vol 50, Iss 12, Pp 2398-2411 (2009)

Increased plasma cholesterol is a known risk factor for cardiovascular disease. Lipoprotein particles transport both cholesterol and triglycerides through the blood. It is thought that the size distribution of these particles codetermines cardiovascu

Externí odkaz: https://doaj.org/article/a77216f8fef340d088ab48069fe0ce86

Hexabody-CD38, a Novel CD38 Antibody with a Hexamerization Enhancing Mutation, Demonstrates Enhanced Complement-Dependent Cytotoxicity and Shows Potent Anti-Tumor Activity in Preclinical Models of Hematological Malignancies

Autor: Grietje Andringa, Andreas Lingnau, Laurens P. Kil, Niels W.C.J. van de Donk, David Satijn, Tuna Mutis, A. Kate Sasser, Kristine A. Frerichs, Andreas Freidig, Tahamtan Ahmadi, Bart De Goeij, Berris van Kessel, Esther C.W. Breij, Maarten L. Janmaat

Publikováno v: De Goeij, B E C G, Janmaat, M L, Andringa, G, Kil, L, Van Kessel, B, Frerichs, K A, Lingnau, A, Freidig, A, Mutis, T, Sasser, A K, Breij, E C W, Van de Donk, N W C J, Ahmadi, T & Satijn, D 2019, ' Hexabody-CD38, a Novel CD38 Antibody with a Hexamerization Enhancing Mutation, Demonstrates Enhanced Complement-Dependent Cytotoxicity and Shows Potent Anti-Tumor Activity in Preclinical Models of Hematological Malignancies ', Blood, vol. 134 . https://doi.org/10.1182/blood-2019-125788
Blood, 134. American Society of Hematology

HexaBody-CD38 (GEN3014) is a novel, hexamerization-enhanced human IgG1 targeting CD38 with superior complement dependent cytotoxicity (CDC) activity, in addition to other effector mechanisms. HexaBody-CD38 carries the E430G mutation and binds a diffe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7dc52409d185e513ba4070482b7ad83c
https://research.vumc.nl/en/publications/5eca2ce7-5698-4119-8c31-e64e1ace7b9d